the use of the three-eyed frog preparation to assay the operation of this fine-tuning mechanism indicates that this process is mediated by the nmda receptor : chronic in vivo treatment with apv , an nmda antagonist , disrupts the segregation of retinal afferents into eye-specific zones while nmda treatment sharpens this pattern .
C0015392
eyed
C0035298
retinal